Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does misoprostol given as a single large dose improve its antisecretory effect?

S G Chiverton1, D W Burget, B J Salena

  • 1Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario, Canada.

Alimentary Pharmacology & Therapeutics
|August 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Influence of Insecticide Resistance, Age, Sex, and Blood Feeding Frequency on Thermal Tolerance of Wild and Laboratory Phenotypes of Anopheles funestus (Diptera: Culicidae).

Journal of medical entomology·2016
Same author

Editorial: towards extended acid suppression--the search continues.

Alimentary pharmacology & therapeutics·2015
Same author

The stomach in health and disease.

Gut·2015
Same author

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need.

Alimentary pharmacology & therapeutics·2014
Same author

Commentary: independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer.

Alimentary pharmacology & therapeutics·2014
Same author

Malaria in South Africa: 110 years of learning to control the disease.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2013

This study tested whether taking a single large dose of the drug misoprostol at night could better reduce stomach acid compared to the standard four-times-daily dosing schedule. Researchers found that while higher single doses did reduce acidity during the night, the overall effect on 24-hour stomach acid levels remained limited.

Area of Science:

  • Gastroenterology research within clinical pharmacology
  • Pharmacodynamics of misoprostol in gastric acid suppression

Background:

Prior research has shown that histamine H2-receptor antagonists effectively suppress nocturnal gastric acidity. That uncertainty drove interest in whether alternative pharmacological agents could achieve similar or superior outcomes. No prior work had resolved if increasing the concentration of a single administration would enhance therapeutic efficacy. This gap motivated an investigation into the dose-response relationship of specific gastric-protective compounds. It was already known that standard dosing protocols often require multiple daily interventions to maintain consistent results. Investigators sought to determine if higher singular quantities might simplify patient compliance while maintaining acid control. The clinical community lacked clear evidence regarding the duration of action for concentrated nocturnal regimens. This study addresses the physiological impact of varied administration schedules on overall intragastric pH levels.

Purpose Of The Study:

The aim of this study was to determine if a single large dose of misoprostol improves its antisecretory effect compared to standard dosing. Researchers sought to resolve whether higher concentrations could provide superior suppression of gastric acid throughout the day. This investigation addressed the clinical need for more efficient administration protocols for patients requiring acid control. The team hypothesized that a concentrated nocturnal dose might simplify treatment while maintaining efficacy. They examined whether the timing and magnitude of the dose influenced the overall duration of action. The study specifically targeted the limitations of existing multi-dose regimens that require frequent patient adherence. By comparing various high-dose strategies, the authors intended to clarify the pharmacodynamic profile of the drug. This work provides a systematic evaluation of how different administration patterns impact the physiological environment of the stomach.

Keywords:
gastric pH monitoringpharmacodynamicsnocturnal acidityclinical pharmacology

Frequently Asked Questions

The researchers propose that 800 micrograms and 600 micrograms of the drug significantly lowered 24-hour acidity compared to the placebo. In contrast, the standard 200 microgram four-times-daily regimen failed to show a statistically significant improvement over the inactive control.

The study utilized a double-blind, randomized, crossover Latin-square design to evaluate 24-hour intragastric pH. This approach allowed for the direct comparison of multiple dosing schedules, including 800, 600, and 400 micrograms, against both placebo and the standard 200 microgram four-times-daily protocol.

Twelve healthy volunteers participated in the trial to ensure controlled monitoring of intragastric pH. This sample size was necessary to provide sufficient statistical power for detecting differences in mean pH levels across the various treatment arms within the crossover framework.

Related Experiment Videos

Main Methods:

The review approach involved a double-blind, randomized, crossover Latin-square design to evaluate pharmacological interventions. Researchers monitored twelve healthy volunteers over a full day to track changes in stomach pH. The team compared several distinct dosing strategies against a placebo control. Evaluated regimens included 800, 600, and 400 micrograms administered at bedtime, alongside an 800 microgram dose taken after supper. These were measured against the standard 200 microgram four-times-daily schedule. Investigators utilized continuous monitoring tools to capture precise fluctuations in acid levels throughout the 24-hour period. This systematic methodology ensured that each participant served as their own control, minimizing individual variability in gastric secretion. The protocol focused on identifying whether concentrated nocturnal administration could outperform traditional multi-dose approaches.

Main Results:

Key findings from the literature demonstrate that the 24-hour mean pH for the placebo group was 2.1 plus or minus 0.3. The standard 200 microgram four-times-daily regimen resulted in a mean pH of 2.2 plus or minus 0.3. Administration of 800 micrograms after supper yielded a mean pH of 2.6 plus or minus 1.1. The 400 microgram bedtime dose achieved a mean pH of 2.6 plus or minus 0.7. Both the 600 and 800 microgram bedtime doses produced a mean pH of 2.6 plus or minus 0.4 and 0.5, respectively. Statistical analysis revealed that only the 600 and 800 microgram doses significantly reduced 24-hour acidity compared to the placebo. These improvements reached significance at a level of P less than 0.04. The data confirm that the drug's impact on gastric acid is restricted to the overnight hours.

Conclusions:

The authors propose that high-dose nocturnal administration provides a modest reduction in total acidity compared to inactive treatments. Synthesis and implications suggest that the therapeutic impact of this drug remains confined to the overnight window. Researchers highlight that increasing the quantity of the medication does not yield a proportional improvement in 24-hour acid control. The findings indicate that the duration of the antisecretory effect is inherently brief regardless of the dose size. Clinical observations reveal that only the highest tested quantities achieved statistically significant differences from the control group. The data imply that traditional frequent dosing schedules may be necessary for sustained suppression throughout the entire day. The investigation confirms that the physiological response to this compound is limited by its rapid metabolic clearance. Future clinical practice should consider these constraints when designing regimens for patients requiring prolonged gastric protection.

The researchers measured the 24-hour mean pH values for each participant. This data type allowed the team to quantify the total antisecretory effect, revealing that the drug's influence on stomach acid was restricted to the nocturnal period rather than providing sustained 24-hour coverage.

The investigators observed that the antisecretory effect was short-lived. While higher doses like 800 micrograms administered at bedtime or after supper increased the mean pH, the impact did not extend throughout the entire day, highlighting the transient nature of the drug's physiological action.

The authors suggest that because the drug's effect is limited to the nocturnal period, it may not be a sufficient replacement for regimens requiring constant acid suppression. They emphasize that the duration of action remains a significant constraint for clinical application.